|
India’s eye care industry is undergoing a structural transformation as the traditional model of independently run practices gives way to organised, institution-led networks. This is propelled by rising demand for quality care, advances in technology, increasing patient expectations, and the need for standardized clinical outcomes as larger eye care platforms are expanding their footprint across the country.
Dr Samsudeen Arikuzhiyan, managing director, Abate AS Industries which is a diversified listed enterprise in healthcare, education, and retail in India and the GCC, said that for decades, eye care in India was built on individual reputation. Patients chose their doctor by name, trust, or word of mouth, and across cities, skilled practitioners built excellent clinics with years of community goodwill. That model worked.
But with the advent of AI (artificial intelligence) in healthcare, the reality is changing. Patients expect more advanced diagnostics and surgical precision, with patient management increasingly moving towards digital. Providing specialised expertise at scale in this environment is challenging, and the next era will require a shift from individual practices to organised, integrated institutions, he added.
As consolidation accelerates, the ophthalmology care future growth will depend not just on scale, but on the ability of institutions to balance clinical excellence, affordability, and accessibility.
A patient anywhere in India can receive the same standard of care and treatment as one in a metro. For towns with little or no access to skilled ophthalmologists, this has made a significant difference, he noted.
We know that the doctor-patient relationship runs on trust, and as eye care networks grow in scale, that trust has to be built into the system itself, not left to individual effort. The newer generation expects transparency and care that is ethically grounded from their doctors. Without governance, that expectation goes unmet. Done well, it holds quality steady across locations and gives institutions the foundation to last, Dr Arikuzhiyan told Pharmabiz.
Investors and regulators note that what begins as a compliance often evolves into an institution’s greatest strategic advantage. Public listings in healthcare are no longer solely about raising capital, but reflect a commitment to governance, transparency, and long-term value creation. As more healthcare companies choose to enter the public markets, the trend signals a broader shift towards institutional scale, stronger accountability, and investor confidence. The rise in healthcare listings is not just a financial story. Going public is more than raising funds. Stricter disclosures force organisational discipline that tends to serve companies well in the long run.
India's eye care sector is at an inflection point. The shift from individual practice to organised, institution-led care is already underway. Models built on sound governance and transparent practices have a natural advantage here. The reach they offer and the operational discipline they demand internally make them better suited to what comes next. What will define India's eye care over the next decade is whether institutions can treat clinical excellence and strong systems not as competing priorities, but as the same thing, said Dr Arikuzhiyan.
|